Brief: China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
28/03/2025 04:07
March 28 (Reuters) - China Shineway Pharmaceutical Group Ltd 2877.HK: GROUP FY NET INCOME RMB 840 MILLION GROUP FY GROSS MARGIN 75% GROUP FY SALES RMB 3,780 MILLION TO DECLARE FIRST INTERIM DIVIDEND FOR 2025 OF RMB36 CENTS PER SHARE Further company coverage: 2877.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Shineway Pharmaceutical
See all newsBrief: China Shineway Pharmaceutical Posts Q1 Turnover Of RMB624 MLN
Brief: China Shineway Pharmaceutical Declares 2026 First Interim Dividend RMB43 Cents Per Share
Brief: China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
Brief: China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
Brief: China Shineway Pharmaceutical Group Posts H1 Net Income RMB 626.5 Mln